Polymorphic DNA markers can now be used for presymptomatic and prenatal diagnosis of the autosomal dominant form of polycystic kidney disease (PKD). A detailed map is known for the chromosomal region around the PKD1 gene on the short arm of chromosome 16. We present here a simple, two step procedure for diagnosis of PKD1 by family studies. Using this approach, at least 92% of random subjects are informative for polymorphic DNA markers bracketing the PKD1 gene. The recombination rate between these flanking markers is on average 10%. In non-recombinants (90% of family members), the accuracy of diagnosis using DNA markers is >99%. We conclude that sufficient well defined DNA markers are now available for routine diagnosis of PKD1.
The slow but relentless growth of cysts in the kidney commonly leads to end stage renal failure at the age of 40 to 60 years. At the time the disease is detected, most patients have already passed on the mutation to their offspring. For genetic counselling, a reliable method for presymptomatic and prenatal diagnosis is needed. As a first step, the mutation responsible for polycystic kidney disease (PKD1) was mapped to the short arm of chromosome 16,' closely linked to 3'HVR, a highly polymorphic DNA marker, located 8 kb downstream from the 3' end of the haemoglobin a gene cluster. [1] [2] [3] Recently, several families with autosomal dominant PKD have been described where the mutation was not linked to genetic markers on chromosome 16,4 5 indicating genetic heterogeneity of PKD. A series of probes for the short arm of chromosome 16 has been developed since.S8 The purpose of this study was to combine the probes isolated by a number of different groups (see table 1 for PIC values). In Two step procedurefor early diagnosis ofpolycystic kidney disease unth polymorphic DNA markers on both sides ofthe gene this way a haplotype of linked markers is constructed for the affected chromosome. In large families, the haplotype can be derived with a high degree of confidence, leading to reliable predictions of PKD1 in a diagnostic situation. However, in practice, small family size often leads to an uncertain linkage phase of the markers, further complicated by double heterozygous matings and recombination. The recombination rate between 3'HVR and 24-1 or CRI-090 is approximately 10%.8 Usually, recombinations can be mapped, or phase problems can be resolved with the second set of markers (see below).
Step 2 The blots from step 1 are stripped and hybridised with a second set of probes ( 
